141 related articles for article (PubMed ID: 36591295)
1. Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images.
Tan J; Liu C; Li Y; Ma Y; Xie R; Li Z; Wan H; Lui S; Wu M
Front Immunol; 2022; 13():1029656. PubMed ID: 36591295
[TBL] [Abstract][Full Text] [Related]
2. Automatic segmentation and RECIST score evaluation in osteosarcoma using diffusion MRI: A computer aided system process.
Baidya Kayal E; Kandasamy D; Yadav R; Bakhshi S; Sharma R; Mehndiratta A
Eur J Radiol; 2020 Dec; 133():109359. PubMed ID: 33129104
[TBL] [Abstract][Full Text] [Related]
3. Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST.
Fenerty KE; Folio LR; Patronas NJ; Marté JL; Gulley JL; Heery CR
BMC Cancer; 2016 Aug; 16(1):672. PubMed ID: 27553491
[TBL] [Abstract][Full Text] [Related]
4. Automatic segmentation of hepatic metastases on DWI images based on a deep learning method: assessment of tumor treatment response according to the RECIST 1.1 criteria.
Liu X; Wang R; Zhu Z; Wang K; Gao Y; Li J; Zhang Y; Wang X; Zhang X; Wang X
BMC Cancer; 2022 Dec; 22(1):1285. PubMed ID: 36476181
[TBL] [Abstract][Full Text] [Related]
5. Response evaluation for immunotherapy through semi-automatic software based on RECIST 1.1, irRC, and iRECIST criteria: comparison with subjective assessment.
Lai YC; Chang WC; Chen CB; Wang CL; Lin YF; Ho MM; Cheng CY; Huang PW; Hsu CW; Lin G
Acta Radiol; 2020 Jul; 61(7):983-991. PubMed ID: 31739675
[TBL] [Abstract][Full Text] [Related]
6. Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastases.
Winter KS; Hofmann FO; Thierfelder KM; Holch JW; Hesse N; Baumann AB; Modest DP; Stintzing S; Heinemann V; Ricke J; Sommer WH; D'Anastasi M
Eur Radiol; 2018 Nov; 28(11):4839-4848. PubMed ID: 29736851
[TBL] [Abstract][Full Text] [Related]
7. Size determination and response assessment of liver metastases with computed tomography--comparison of RECIST and volumetric algorithms.
Rothe JH; Grieser C; Lehmkuhl L; Schnapauff D; Fernandez CP; Maurer MH; Mussler A; Hamm B; Denecke T; Steffen IG
Eur J Radiol; 2013 Nov; 82(11):1831-9. PubMed ID: 22717124
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome.
Aghighi M; Boe J; Rosenberg J; Von Eyben R; Gawande RS; Petit P; Sethi TK; Sharib J; Marina NM; DuBois SG; Daldrup-Link HE
Radiology; 2016 Sep; 280(3):905-15. PubMed ID: 26982677
[TBL] [Abstract][Full Text] [Related]
9. [Value of dual-energy CT-based volumetric iodine-uptake in the evaluation of chemotherapy efficacy in advanced gastric cancer].
Chen LF; Fu GZ; Huang DP; Man Y; Jin Y; Dong QT; Huang YB; Chen YC; Wang HQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):977-983. PubMed ID: 31630497
[No Abstract] [Full Text] [Related]
10. Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization.
Li Z; Bonekamp S; Halappa VG; Corona-Villalobos CP; Pawlik T; Bhagat N; Reyes D; Lai H; Geschwind JF; Kamel IR
Radiology; 2012 Jul; 264(1):97-109. PubMed ID: 22627602
[TBL] [Abstract][Full Text] [Related]
11. Volumetric glioma quantification: comparison of manual and semi-automatic tumor segmentation for the quantification of tumor growth.
Odland A; Server A; Saxhaug C; Breivik B; Groote R; Vardal J; Larsson C; Bjørnerud A
Acta Radiol; 2015 Nov; 56(11):1396-403. PubMed ID: 25338837
[TBL] [Abstract][Full Text] [Related]
12. Semi-automatic volumetric measurement of response to chemotherapy in lung cancer patients: How wrong are we using RECIST?
Greenberg V; Lazarev I; Frank Y; Dudnik J; Ariad S; Shelef I
Lung Cancer; 2017 Jun; 108():90-95. PubMed ID: 28625656
[TBL] [Abstract][Full Text] [Related]
13. RECIST 1.1 Target Lesion Categorical Response in Metastatic Renal Cell Carcinoma: A Comparison of Conventional versus Volumetric Assessment.
Gong AJ; Ruchalski K; Kim HJ; Douek M; Gutierrez A; Patel M; Sai V; Coy H; Villegas B; Raman S; Goldin J
Radiol Imaging Cancer; 2023 Sep; 5(5):e220166. PubMed ID: 37656041
[TBL] [Abstract][Full Text] [Related]
14. Comparison of CT volumetric measurement with RECIST response in patients with lung cancer.
Hayes SA; Pietanza MC; O'Driscoll D; Zheng J; Moskowitz CS; Kris MG; Ginsberg MS
Eur J Radiol; 2016 Mar; 85(3):524-33. PubMed ID: 26860663
[TBL] [Abstract][Full Text] [Related]
15. Tumor growth kinetics versus RECIST to assess response to locoregional therapy in breast cancer liver metastases.
Seyal AR; Parekh K; Velichko YS; Salem R; Yaghmai V
Acad Radiol; 2014 Aug; 21(8):950-7. PubMed ID: 24833565
[TBL] [Abstract][Full Text] [Related]
16. A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma.
Kanaly CW; Mehta AI; Ding D; Hoang JK; Kranz PG; Herndon JE; Coan A; Crocker I; Waller AF; Friedman AH; Reardon DA; Sampson JH
J Neurosurg; 2014 Sep; 121(3):536-42. PubMed ID: 25036205
[TBL] [Abstract][Full Text] [Related]
17. Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma.
Bonekamp D; Bonekamp S; Halappa VG; Geschwind JF; Eng J; Corona-Villalobos CP; Pawlik TM; Kamel IR
Eur J Radiol; 2014 Mar; 83(3):487-96. PubMed ID: 24387824
[TBL] [Abstract][Full Text] [Related]
18. Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas.
Shah GD; Kesari S; Xu R; Batchelor TT; O'Neill AM; Hochberg FH; Levy B; Bradshaw J; Wen PY
Neuro Oncol; 2006 Jan; 8(1):38-46. PubMed ID: 16443946
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data.
Bonekamp S; Jolepalem P; Lazo M; Gulsun MA; Kiraly AP; Kamel IR
Radiology; 2011 Sep; 260(3):752-61. PubMed ID: 21771960
[TBL] [Abstract][Full Text] [Related]
20. MRI volume measurements compared with the RECIST 1.1 for evaluating the response to neoadjuvant chemotherapy for mass-type lesions.
An YY; Kim SH; Kang BJ; Lee AW; Song BJ
Breast Cancer; 2014 May; 21(3):316-24. PubMed ID: 22767314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
